Skip to Content

Ozenoxacin use while Breastfeeding

Drugs containing Ozenoxacin: Xepi

Medically reviewed by Drugs.com. Last updated on Feb 12, 2021.

Ozenoxacin Levels and Effects while Breastfeeding

Summary of Use during Lactation

No information is available on ozenoxacin cream during breastfeeding. Because ozenoxacin is poorly absorbed after topical application, it is not likely to reach the bloodstream of the infant or cause any adverse effects in breastfed infants after maternal application away from the breast. Although quinolones are generally acceptable for systemic use, ozenoxacin should be avoided on the nipple because the infant could ingest the drug via licking.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Mupirocin

Substance Identification

Substance Name

Ozenoxacin

CAS Registry Number

245765-41-7

Drug Class

  • Breast Feeding
  • Lactation
  • Quinolones
  • Anti-Infective Agents, Local
  • Anti-Bacterial Agents

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.